|
[1]
|
Mitochondrial Disruption by Amyloid Beta 42 Identified by Proteomics and Pathway Mapping
Cells,
2021
DOI:10.3390/cells10092380
|
|
|
|
|
[2]
|
Mitochondrial Disruption by Amyloid Beta 42 Identified by Proteomics and Pathway Mapping
Cells,
2021
DOI:10.3390/cells10092380
|
|
|
|
|
[3]
|
Phytoconstituents and their Possible Mechanistic Profile for Alzheimer’s Disease – A Literature Review
Current Drug Targets,
2019
DOI:10.2174/1389450119666180813095637
|
|
|
|
|
[4]
|
The concept of hybrid molecules of tacrine and benzyl quinolone carboxylic acid (BQCA) as multifunctional agents for Alzheimer's disease
European Journal of Medicinal Chemistry,
2018
DOI:10.1016/j.ejmech.2018.02.083
|
|
|
|
|
[5]
|
Induction of nerve growth factor by phorbol 12-myristate 13-acetate is dependent upon the mitogen activated protein kinase pathway
Heliyon,
2018
DOI:10.1016/j.heliyon.2018.e00617
|
|
|
|
|
[6]
|
Induction of nerve growth factor by phorbol 12-myristate 13-acetate is dependent upon the mitogen activated protein kinase pathway
Heliyon,
2018
DOI:10.1016/j.heliyon.2018.e00617
|
|
|
|
|
[7]
|
Protein Expression of BACE1 is Downregulated by Donepezil in Alzheimer’s Disease Platelets
Journal of Alzheimer's Disease,
2016
DOI:10.3233/JAD-160813
|
|
|
|
|
[8]
|
Anti-dementia medications: current prescriptions in clinical practice and new agents in progress
Therapeutic Advances in Drug Safety,
2015
DOI:10.1177/2042098615592116
|
|
|
|
|
[9]
|
Anti-dementia medications: current prescriptions in clinical practice and new agents in progress
Therapeutic Advances in Drug Safety,
2015
DOI:10.1177/2042098615592116
|
|
|
|
|
[10]
|
Development of Bioactive Ceramics to Control Mite and Microbial Diseases in Bee Farms
Advanced Materials Research,
2010
DOI:10.4028/www.scientific.net/AMR.93-94.553
|
|
|
|